Nilsson, Peter M <br/><br/>
Hemodynamic effects by glucagon-like peptide-1 receptor analogues: what should be measured?  [electronic resource] 

 -  Journal of hypertension  05 2017 
 - 953-954 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1473-5598 
<br/><br/><label>Standard No.: </label>10.1097/HJH.0000000000001315  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Glucagon-Like Peptide 1<br/>Glucagon-Like Peptide-1 Receptor<br/>Hemodynamics<br/>Humans<br/>Insulin<br/>Peptide Fragments<br/>Peptides